Long-Term Efficacy and Safety of Fluorometholone 0.1% Use After Descemet Membrane Endothelial Keratoplasty
Long-term use of fluorometholone 0.1% after DMEK results in low rates of steroid induced ocular hypertension, de novo glaucoma, and immunologic rejection in patients without prior glaucoma.
Authors
- Neeti Gupta (ORCID: https://orcid.org/0000-0001-8395-7913)
- Marianne O. Price (ORCID: https://orcid.org/0000-0002-6652-534X)
- Francis W. Price (ORCID: https://orcid.org/0000-0001-9298-0250)
Institutions
- Cornea Research Foundation of America (US)
- Price Vision Group (US)
- All India Institute of Medical Sciences Rishikesh (IN)
Publication Details
- Journal
- Cornea
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1097/ico.0000000000003846
- Citations
- 1
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.71